Colchicine in COVID-19: an Old Drug, New Use | Current Pharmacology Reports
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Respiratory Medicine
Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial - eClinicalMedicine
The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis - Monireh Golpour, Tahoora Mousavi, Mina Alimohammadi, Ali Mosayebian, Mohammadreza Shiran, Reza Alizadeh Navaei, Alireza Rafiei,
Colchicine Tablets: Package Insert - Drugs.com
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial - The Lancet Respiratory Medicine
Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial - The Lancet Rheumatology
Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions
Frontiers | Colchicine in atrial fibrillation: are old trees in bloom?
Frontiers | Case Report: Colchicine Toxicokinetic Analysis in a Poisoned Child Requiring Extracorporeal Life Support
Colchicine in Patients with Chronic Coronary Disease | NEJM
A Price Jump From Pennies to $20/Pill for the Same Drug | MedPage Today
Colchicine and aspirin in community patients with COVID-19 (ACT): an open- label, factorial, randomised, controlled trial - The Lancet Respiratory Medicine
Colchicine in Cardiovascular Disease: In-Depth Review | Circulation
Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial - The Lancet Rheumatology
JCM | Free Full-Text | Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
Agepha Pharma's Lodoco Anti-Inflammatory Drug for Cardiovascular Disease Approved by FDA - Cardiac Interventions Today
Low-Dose Colchicine for Coronary Artery Disease | The Medical Letter Inc.
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management | Drug Safety
Rx OnlyThese highlights do not include all the information needed to use COLCHICINE CAPSULES safely and effectively. See full prescribing information for COLCHICINE CAPSULES. COLCHICINE capsules, for oral useInitial U.S. Approval: 1961
Colchicine Against SARS-CoV-2 Infection: What is the Evidence? | Rheumatology and Therapy
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology - Next Steps in Dermatology
IJMS | Free Full-Text | Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence
These highlights do not include all the information needed to use COLCHICINE TABLETS safely and effectively. See full prescribing information for COLCHICINE TABLETS. COLCHICINE tablets, for oral use Initial U.S. Approval: 1961
